--- title: "VSEE HEALTH INC C/WTS (TO PUR COM) | 10-Q: FY2026 Q1 Revenue: USD 3.16 M" type: "News" locale: "en" url: "https://longbridge.com/en/news/286603957.md" datetime: "2026-05-15T19:25:22.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/286603957.md) - [en](https://longbridge.com/en/news/286603957.md) - [zh-HK](https://longbridge.com/zh-HK/news/286603957.md) --- # VSEE HEALTH INC C/WTS (TO PUR COM) | 10-Q: FY2026 Q1 Revenue: USD 3.16 M Revenue: As of FY2026 Q1, the actual value is USD 3.16 M. EPS: As of FY2026 Q1, the actual value is USD -0.05. EBIT: As of FY2026 Q1, the actual value is USD -2.861 M. ### Consolidated Financial Performance #### Net Loss VSee Health, Inc. reported a net loss of - $2,600,262 for the three months ended March 31, 2026, which is a 34% decrease compared to a net loss of - $3,959,440 for the same period in 2025. #### Gross Margin Consolidated gross margin was $1,198,111 (38% of revenue) for the three months ended March 31, 2026, a -36% decrease from $1,859,971 (56% of revenue) in the prior-year period. #### Operating Expenses Total operating expenses increased by 13% to $4,172,386 for the three months ended March 31, 2026, from $3,691,289 in the prior-year period. Compensation and related benefits increased by 4% to $1,732,003, while general and administrative expenses rose by 20% to $2,440,383. #### Other Income (Expense) Other income (expense), net, improved significantly from a net expense of - $2,114,617 in 2025 to a net income of $397,751 in 2026. This improvement was driven by a positive change in the fair value of financial instruments of $1,404,511, a gain on extinguishment of financial liabilities of $367,809, and a reduction in interest expense of $617,567. ### Segmented Performance (Three Months Ended March 31) #### Technology Segment - **Revenues**: Totaled $1,280,892 in 2026, down from $2,123,871 in 2025. Subscription fees decreased by -27% to $605,470 from $827,345, professional services and other fees decreased by -35% to $580,981 from $896,680, and technical engineering fees decreased by -76% to $94,441 from $399,846. - **Cost of Revenues**: Decreased to $810,193 in 2026 from $1,074,124 in 2025. - **Gross Margin**: Decreased to $470,699 in 2026 from $1,049,747 in 2025. - **Segment Operating Loss**: Increased to - $1,314,742 in 2026 from - $354,237 in 2025. - **Assets**: Totaled $605,513 as of March 31, 2026, compared to $664,525 as of December 31, 2025. #### Telehealth Segment - **Revenues**: Totaled $1,879,293 in 2026, up from $1,197,614 in 2025. Patient fees increased by 24% to $881,340 from $711,264, telehealth fees increased by 106% to $997,953 from $483,850, and institutional fees were $0 in 2026, down from $2,500 in 2025. - **Cost of Revenues**: Increased to $1,151,881 in 2026 from $387,390 in 2025. - **Gross Margin**: Decreased to $727,412 in 2026 from $810,224 in 2025. - **Segment Operating Loss**: Decreased to - $785,061 in 2026 from - $583,174 in 2025. - **Assets**: Totaled $16,656,643 as of March 31, 2026, compared to $17,150,543 as of December 31, 2025. ### Cash Flows - **Net cash used in operating activities**: Increased to - $2,452,191 for the three months ended March 31, 2026, from - $440,493 in the prior-year period. - **Net cash used in investing activities**: Increased to - $126,752 for the three months ended March 31, 2026, from - $11,873 in the prior-year period, primarily due to fixed asset purchases and investments. - **Net cash used in financing activities**: Was - $1,341,211 for the three months ended March 31, 2026, primarily due to repayment of notes payable, finance lease, and line of credit, compared to an inflow of $536,373 in the prior-year period. ### Strategic Outlook VSee Health, Inc. aims to capitalize on the rapid transformation of the telehealth market, which it believes indicates strong future growth and offers an attractive value proposition to healthcare systems. The company plans to expand its market share by leveraging industry relationships with government, hospital systems, and insurance providers. A core strategy involves continuous innovation and new product offerings, focusing on technology solutions that meet healthcare performance and compliance standards, integrate patient data, and enhance sophisticated video engagement. ### Related Stocks - [VSEEW.US](https://longbridge.com/en/quote/VSEEW.US.md) ## Related News & Research - [VSee Health Secures New Private Debt Financing Agreement](https://longbridge.com/en/news/289512103.md) - [Watts Named One of Newsweek’s World’s Greenest Companies 2026 | WTS Stock News](https://longbridge.com/en/news/288780004.md) - [How Investors Are Reacting To Cardinal Health (CAH) Raising Guidance While Expanding Theranostics Amid Recall](https://longbridge.com/en/news/288985099.md) - [13:11 ETTransformational Coach and Bestselling Author Lainie Etzioni Launches The Unbecoming Method to Help Women Finally Change It](https://longbridge.com/en/news/289496391.md) - [BOXABL Unveils Rego-Brix Concept for Radiation Shielding Using Lunar Regolith | FGMC Stock News](https://longbridge.com/en/news/289478481.md)